Roche provides update on Alzheimer’s Prevention Initiative study evaluating crenezumab in autosomal dominant Alzheimer’s disease
Crenezumab did not slow or prevent cognitive decline in people with a specific genetic mutation which causes early-onset Alzheimer’s disease For more than a decade Roche has been working in collaboration with Banner Alzheimer’s Institute, the University of Antioquia in Colombia and the National Institute on Aging on this pioneering prevention study Initial data will […]
Roche receives FDA EUA for cobas SARS-CoV-2 Duo, the first PCR test to simultaneously detect COVID-19 and quantitatively measure viral load levels of COVID-19
The cobas SARS-CoV-2 Duo test combines the standard qualitative result of a traditional SARS-CoV-2 PCR test with a quantitative result, which measures the viral load of a patient suspected of COVID-19. Potential benefits of the cobas SARS-CoV-2 Duo test aim to help the healthcare community with contact tracing, patient triage and the approach to medical […]
Virtual Press Conference on COVID-19 and other global health issues
Good morning, good afternoon and good evening, Today is World Blood Donor Day. Blood donations are a lifeline in emergencies, disasters, humanitarian crises, and for people who need regular transfusions. And yet around the world, many communities do not have access to safe blood. Women and children are the most at risk. So please, give […]
National Health Authority (NHA) organised a conclave on Ayushman Bharat Digital Mission (ABDM) – Revolutionizing Digital Health in association with NASSCOM
The National Health Authority (NHA) and NASSCOM (National Association of Software and Service Companies) jointly organized the NHA-NASSCOM Conclave 2022 on Ayushman Bharat Digital Mission – Revolutionizing Digital Health. The Conclave was held in Bengaluru today as a hybrid event with participation of over 400 stakeholders and industry veterans from the healthcare & technology sector […]
Dr. Bharati Pravin Pawar launches Intensified Diarrhoea Control Fortnight – 2022 aimed at zero child deaths due to childhood diarrhoea
Union Minister of State for Health and Family Welfare, Dr Bharati Pravin Pawar today launched the Intensified Diarrhoea Control Fortnight (IDCF)-2022 in the presence of Dr. Sapam Ranjan Singh, Health Minister of Manipur. IDCF programme is being implemented from 13th June to 27th June, 2022 in the States/UTs. The goal of IDCF is to attain […]
Roche announces positive data from broad blood cancer portfolio at European Hematology Association Annual Meeting
Long-term data at the European Hematology Association (EHA) 2022 congress expands understanding of the impact of Roche medicines in early-stage blood cancers with the goal of providing patients with robust and durable outcomes from their first treatment Updated data from phase III CLL14 study of Venclexta®/Venclyxto® (venetoclax) plus Gazyva®/Gazyvaro® (obinutuzumab) showed more than 60% of […]
European Commission approves Roche’s Tecentriq as adjuvant treatment for a subset of people with early-stage non-small cell lung cancer
In the Phase III IMpower010 trial, adjuvant Tecentriq reduced the risk of disease recurrence or death by 57% in people with PD-L1 high resected Stage II-III NSCLC, compared with best supportive care Tecentriq is now the first and only cancer immunotherapy available for certain people with early-stage NSCLC in Europe Today’s approval marks Tecentriq’s sixth […]
U.S. FDA approves Foundation Medicine’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib)
FoundationOne CDx can now be used to identify patients with ROS1 fusion-positive non-small cell lung cancer or patients with NTRK fusion-positive solid tumours for whom treatment with Rozlytrek may be appropriate This approval marks the first and only companion diagnostic indication for Rozlytrek, and another important milestone in tumour-agnostic approaches for people living with rare […]
European Commission approves Roche’s first-in-class bispecific antibody Lunsumio for people with relapsed or refractory follicular lymphoma
Lunsumio® (mosunetuzumab) is the first CD20xCD3 T-cell engaging bispecific antibody available to treat the most common slow-growing form of non-Hodgkin lymphoma, follicular lymphoma (FL) Lunsumio represents a new type of immunotherapy that is a chemotherapy-free, off-the-shelf, fixed-duration treatment option that could improve outcomes for people who have relapsed or are refractory to multiple previous treatments […]
Multi-country monkeypox outbreak: situation update
Since 13 May 2022, and as of 2 June 2022, 780 laboratory confirmed cases of monkeypox have been reported to or identified by WHO from 27 Member States across four WHO regions that are not endemic for monkeypox virus. Epidemiological investigations are ongoing. Most reported cases so far have been presented through sexual health or […]
